Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021-06-23 to 2021-10-04
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 luciferase KeratinoSens™ test method)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- ARE-Nrf2 luciferase KeratinoSens™ test method
Test material
- Reference substance name:
- 2-Propenoic acid, 2-methyl-, 3-methyl-3-buten-1-yl ester
- Cas Number:
- 156291-88-2
- Molecular formula:
- C9H14O2
- IUPAC Name:
- 2-Propenoic acid, 2-methyl-, 3-methyl-3-buten-1-yl ester
- Reference substance name:
- Mequinol
- EC Number:
- 205-769-8
- EC Name:
- Mequinol
- Cas Number:
- 150-76-5
- IUPAC Name:
- (Polymerization inhibitor) 4-Methoxyphenol
Constituent 1
additive 1
In vitro test system
- Details of test system:
- Keratinoses transgenic cell line [442D]
- Details on the study design:
- see under "Any other information on materials and methods incl. tables"
- Vehicle / solvent control:
- DMSO
- Negative control:
- other: DMSO at a final concentration of 1% (v/v) in test item exposure medium was used as negative control.
- Positive control:
- cinnamic aldehyde [442D]
Results and discussion
- Positive control results:
- Refer to the experiment 1-3 results in the pdf attachment.
In vitro / in chemico
Resultsopen allclose all
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- Imax [442D]
- Value:
- 1.66
- At concentration:
- 500 other: µM
- Cell viability:
- 149.8%
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: The corresponding cell viability determined by MTT staining was 149.8%.
- Remarks:
- Microscopically, a clear cytotoxic effect was observed at the three highest test item concentrations (500, 1000 and 2000 µM) and a slight cytotoxic effect at a test item concentration of 250 µM. The increase in % viability may be caused by a slight MTT reducing potential of the test item, as determined in a MTT interference test. Therefore, the slight induction above the threshold of 1.5 may be caused by the cytotoxic effect.
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 3
- Parameter:
- Imax [442D]
- Value:
- 2.61
- At concentration:
- 756.14 other: µM
- Cell viability:
- 87.6 %.
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Group:
- test chemical
- Run / experiment:
- run/experiment 2
- Parameter:
- Imax [442D]
- Value:
- 1.41
- At concentration:
- 500 other: µM
- Cell viability:
- 87.4%
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: In the second experiment, no significant luciferase induction > 1.5 was found in the tested concentration range.
- Remarks:
- Therefore, no EC1.5 value could be calculated. To verify the results and as the test item induced the gene activity very close to the cytotoxic level in experiment 1, a third experiment with an adapted concentration range and a narrower dose-response analysis with dilution of 1.15-fold was performed to decide if induction is at cytotoxic levels or not.
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- EC 1.5 [442D]
- Value:
- 289.06 µM
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: The corresponding cell viability determined by MTT staining was 149.8%.
- Remarks:
- Microscopically, a clear cytotoxic effect was observed at the three highest test item concentrations (500, 1000 and 2000 µM) and a slight cytotoxic effect at a test item concentration of 250 µM. The increase in % viability may be caused by a slight MTT reducing potential of the test item, as determined in a MTT interference test. Therefore, the slight induction above the threshold of 1.5 may be caused by the cytotoxic effect.
- Group:
- test chemical
- Run / experiment:
- run/experiment 3
- Parameter:
- EC 1.5 [442D]
- Value:
- 313.33 µM
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: The lowest tested concentration with a significant luciferase induction >1.5 (1.55) was found to be 326.90 µM. The corresponding cell viability was >70% (97.9%). The calculated EC1.5 was <1000 µM (313.33 µM).
- Outcome of the prediction model:
- positive [in vitro/in chemico]
- Other effects / acceptance of results:
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: yes
- Range of historical values if different from the ones specified in the test guideline: see table below
Any other information on results incl. tables
The in vitro KeratinoSens™ assay enables detection of the sensitising potential of a test item by addressing the second molecular key event of the adverse outcome pathway (AOP), namely activation of keratinocytes, by quantifying the luciferase activity in the transgenic cell line KeratinoSens™. The luciferase activity, assessed by luminescence measurement, compared to the respective solvent controls is used to support discrimination between skin sensitisers and non-sensitisers.
In the present study 1,3-di(3-Methyl-2-butenoxy)-2-hydroxypropane was dissolved in DMSO.
Based on a molecular weight of 228.33 g/mol a stock solution of 200 mM was prepared.
Based on the stock solution a set of twelve master solutions in 100% solvent was prepared by serial dilution using a constant dilution factor of 1:2. These master solutions were diluted 1:100 in cell culture medium. The following concentration range was tested in the assay:
2000, 1000, 500, 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95, 0.98 µM
Cells were incubated with the test item for 48 h at 37°C. After exposure cells were lysed and luciferase activity was assessed by luminescence measurement.
In the first experiment, a max luciferase activity (Imax) induction of 2.91 was determined at a test item concentration of 2000 µM. The corresponding cell viability was 93.9%. The lowest tested concentration with a significant luciferase induction >1.5 (1.80) was found to be 500 µM. The corresponding cell viability was >70% (121.0%). The calculated EC1.5 was <1000 µM (256.25 µM).
In the second experiment, a max luciferase activity (Imax) induction of 5.55 was determined at a test item concentration of 2000 µM. The corresponding cell viability was 64.7%. The lowest tested concentration with a significant luciferase induction >1.5 (1.86) was found to be 500 µM. The corresponding cell viability was >70% (97.2%). The calculated EC1.5 was <1000 µM (253.54 µM).
A dose response for luciferase activity induction was observed for each individual run as well as for an overall luciferase activity induction.
Under the condition of this study the test item is therefore considered as sensitiser.
The controls confirmed the validity of the study (see Table 6).
Luciferase Activity - Overall Induction
Table 5: Induction of Luciferase Activity – Overall Induction
Conc. |
Experiment 1 |
Experiment 2 |
Conc. |
Experiment 3 |
||||||
[µM] |
mean |
sd |
Sign. |
mean |
sd |
Sign. |
[µM] |
mean |
sd |
Sign. |
0.98 |
1.22 |
0.12 |
|
1.13 |
0.32 |
|
214.94 |
1.44 |
0.07 |
|
1.95 |
1.30 |
0.10 |
|
1.01 |
0.09 |
|
247.18 |
1.38 |
0.18 |
|
3.91 |
1.22 |
0.13 |
|
0.98 |
0.08 |
|
284.26 |
1.39 |
0.09 |
|
7.81 |
1.34 |
0.19 |
|
1.05 |
0.11 |
|
326.90 |
1.55 |
0.27 |
* |
15.63 |
1.24 |
0.09 |
|
1.10 |
0.13 |
|
375.94 |
1.54 |
0.22 |
* |
31.25 |
1.27 |
0.11 |
|
1.15 |
0.18 |
|
432.33 |
1.75 |
0.21 |
* |
62.50 |
1.31 |
0.01 |
|
1.24 |
0.10 |
|
497.18 |
1.58 |
0.21 |
* |
125.00 |
1.38 |
0.08 |
|
1.19 |
0.15 |
|
571.75 |
1.88 |
0.25 |
* |
250.00 |
1.47 |
0.34 |
|
1.37 |
0.38 |
|
657.52 |
1.96 |
0.56 |
* |
500.00 |
1.66 |
0.05 |
* |
1.41 |
0.11 |
|
756.14 |
2.61 |
0.51 |
* |
1000.0 |
0.91 |
0.35 |
|
0.74 |
0.07 |
|
869.57 |
1.91 |
1.42 |
|
2000.0 |
0.02 |
0.01 |
|
0.52 |
0.80 |
|
1000.0 |
0.74 |
0.34 |
|
* = significant induction according to Student’s t-test, p<0.05; grey marked: viability >70%; sign.= significant
Additional Parameters
Table 6: Additional Parameters
Parameter |
Experiment 1 |
Experiment 2 |
Experiment 3 |
Mean |
SD |
EC1.5 |
289.06 |
- |
313.33 |
301.19 |
17.17 |
Imax |
1.66 |
1.41 |
2.61 |
1.89 |
0.63 |
IC30 |
775.28 |
736.75 |
786.88 |
766.30 |
26.24 |
IC50 |
844.29 |
1086.52 |
821.81 |
917.54 |
146.77 |
n.a.=not applicable; [value] excluded due to cytotoxic effects (see discussion)
Acceptance Criteria
Table 7: Acceptance Criteria
Criterion |
Range |
Exp. 1 |
pass/fail |
Exp. 2 |
pass/fail |
Exp. 3 |
pass/fail |
CV Solvent Control [%] |
< 20% |
15.4 |
pass |
9.6 |
pass |
13.5 |
pass |
No. of positive control concentration steps with significant luciferase activity induction >1.5 |
= 1 |
2.0 |
pass |
2.0 |
pass |
3.0 |
pass |
EC1.5 PC [µM] |
± 2 x SD of historical mean |
20.57 |
pass |
16.63 |
pass |
15.16 |
pass |
Induction PC at 64 µM |
2 .00 < x < 8.00 |
2.05 |
pass |
6.65 |
pass |
5.27 |
pass |
Historical Data
Table 8: Historical Data
Acceptance Criterion |
Range |
Mean |
SD |
N |
CV Solvent Control |
< 20% |
11.6 |
3.4 |
186 |
No. of positive control concentration steps with significant luciferase activity induction >1.5 |
= 1 |
2.3 |
0.6 |
186 |
EC1.5 PC |
7 < x < 34 µM |
19.1 |
5.9 |
186 |
Induction PC at 64 µM |
2.00 < x < 8.00 |
3.8 |
1.4 |
186 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- In this study under the given conditions the test item induced the luciferase activity in the transgenic KeratinoSens™ cell line in at least two independent experiment runs. Therefore, the test item might be considered as sensitiser.
The data generated with this test should be considered in the context of integrated approached such as IATA, combining the result with other complementary information, e.g. derived from in vitro assays addressing other key events of the skin sensitisation AOP. - Executive summary:
The in vitro KeratinoSens™ assay enables detection of the sensitising potential of a test item by addressing the second molecular key event of the adverse outcome pathway (AOP), namely activation of keratinocytes, by quantifying the luciferase activity in the transgenic cell line KeratinoSens™. The luciferase activity, assessed by luminescence measurement, compared to the respective solvent controls is used to support discrimination between skin sensitisers and
non-sensitisers.In the first experiment, a max luciferase activity (Imax) induction of 1.66 was determined at a test item concentration of 500 µM. The corresponding cell viability determined by MTT staining was 149.8%. Microscopically, a clear cytotoxic effect was observed at the three highest test item concentrations (500, 1000 and 2000 µM) and a slight cytotoxic effect at a test item concentration of 250 µM. The increase in % viability may be caused by a slight MTT reducing potential of the test item, as determined in a MTT interference test. Therefore, the slight induction above the threshold of 1.5 may be caused by the cytotoxic effect.
In the second experiment, no significant luciferase induction > 1.5 was found in the tested concentration range. Therefore, no EC1.5 value could be calculated.
To verify the results and as the test item induced the gene activity very close to the cytotoxic level in experiment 1, a third experiment with an adapted concentration range and a narrower dose-response analysis with dilution of 1.15-fold was performed to decide if induction is at cytotoxic levels or not.
In the third experiment, a max luciferase activity (Imax) induction of 2.61 was determined at a test item concentration of 756.14 µM. The corresponding cell viability was 87.6 %. The lowest tested concentration with a significant luciferase induction >1.5 (1.55) was found to be 326.90 µM. The corresponding cell viability was >70% (97.9%). The calculated EC1.5 was <1000 µM (313.33 µM).
A dose response for luciferase activity induction was observed for experiment 1 and experiment 3.
Under the condition of this study the test item is therefore considered positive.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
